Milestone Scientific Inc. Share Price

Equities

MLSS

US59935P2092

Advanced Medical Equipment & Technology

Market Closed - Nyse 01:30:00 21/06/2024 am IST 5-day change 1st Jan Change
0.67 USD -1.47% Intraday chart for Milestone Scientific Inc. -4.88% -2.88%
Sales 2024 * 10.3M 861M Sales 2025 * 11.85M 990M Capitalization 51.74M 4.32B
Net income 2024 * -4M -334M Net income 2025 * -3M -251M EV / Sales 2024 * 5.02 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.37 x
P/E ratio 2024 *
-13.4 x
P/E ratio 2025 *
-13.4 x
Employees 17
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.84%
More Fundamentals * Assessed data
Dynamic Chart
Milestone Scientific Says CompuFlo Epidural System Gains Approval in Brazil MT
Milestone Scientific Receives Regulatory Approval to Market Compuflo Epidural System in Brazil CI
Transcript : Milestone Scientific Inc., Q1 2024 Earnings Call, May 16, 2024
Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Certain Common Stock of Milestone Scientific Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024. CI
Milestone Scientific Inc. Commences Sales of CompuFlo Epidural Disposables Within PRCAlliance Pain Relief Center in Ormond Beach, Florida CI
Transcript : Milestone Scientific Inc., 2023 Earnings Call, Apr 01, 2024
Milestone Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Milestone Scientific Inc. Commences Sales of Compuflo Epidural Disposables Within Omaha Pain Physicians CI
Milestone Scientific Inc. Commences Sales of STA Single Tooth Anesthesia System to Maine Dental Group CI
Milestone Scientific Closes $3 Million Stock Offering MT
Milestone Scientific Prices $3 Million Stock Offering at $0.63 a Share MT
Milestone Scientific Starts Sales of CompuFlo for Use in Spinal Cord Stimulator Implantation Procedures MT
Milestone Scientific Inc. Announces Agreement with Bioline Supply to Distribute the Compuflo®? Epidural System and Related Disposables Across Spain CI
Transcript : Milestone Scientific Inc., Q3 2023 Earnings Call, Nov 15, 2023
More news
1 day-1.47%
1 week-4.88%
Current month-7.95%
1 month-6.28%
3 months+2.92%
6 months+11.52%
Current year-2.88%
More quotes
1 week
0.65
Extreme 0.6501
0.85
1 month
0.65
Extreme 0.6501
0.85
Current year
0.52
Extreme 0.52
0.85
1 year
0.52
Extreme 0.52
1.35
3 years
0.41
Extreme 0.405
3.00
5 years
0.32
Extreme 0.3201
4.85
10 years
0.26
Extreme 0.26
4.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/20/01
Chief Tech/Sci/R&D Officer 63 01/99/01
Director/Board Member 76 01/91/01
Members of the board TitleAgeSince
Director/Board Member 76 01/91/01
Director/Board Member 63 14/14/14
Chairman 80 03/19/03
More insiders
Date Price Change Volume
20/24/20 0.67 -1.47% 113,865
18/24/18 0.68 -8.10% 613,821
17/24/17 0.7399 +2.76% 148,388
14/24/14 0.72 +2.21% 117,922
13/24/13 0.7044 -2.17% 62,787

Delayed Quote Nyse, June 21, 2024 at 01:30 am IST

More quotes
Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.67 USD
Average target price
3 USD
Spread / Average Target
+347.76%
Consensus